Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 72Terminated 10Unknown 9Recruiting 6Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 12Other hematologic neoplasm 11Sarcoma 6Plasma cell 5Myeloid 5Other solid neoplasm 3Thoracic 2CNS 2Gastrointestinal 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Central Nervous System Neoplasms 2Sarcoma 1Retinoblastoma 1Oligodendroglioma 1Neuroblastoma 1Gliosarcoma 1Glioblastoma 1Choroid Plexus Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 19Magnetic Resonance Spectroscopy 16Radiosurgery 12Bevacizumab 12Radiotherapy 10Radiation 8pembrolizumab 6Specimen Handling 6Methotrexate 6Surgical Procedures, Operative 5Topotecan 4TIC10 compound 4Isotretinoin 4Carmustine 4Carboplatin 4abemaciclib 3Trastuzumab 3Thiotepa 3Standard of Care 3Nivolumab 3Magnetic Resonance Imaging 3Lomustine 3Irinotecan 3Erlotinib Hydrochloride 3Drug Therapy 3Dexamethasone 3vandetanib 2thymoglobulin 2temsirolimus 2pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Filgrastim × CNS × Clear all
NCT00003273 2015-12-03

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

NYU Langone Health

Phase 2 Withdrawn
CNSOther solid neoplasmSarcoma

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

NCT00006263 2015-08-05

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

NYU Langone Health

Phase 2 Withdrawn
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡